Carregant...
Rituximab Treatment for Nephrotic Syndrome in Children
In the past 10 years, many reports have suggested that rituximab, a chimeric anti-CD20 monoclonal antibody, is effective for children with complicated, frequently relapsing or steroid-dependent nephrotic syndrome (FRNS/SDNS). However, those reports were case reports, case series, retrospective surve...
Guardat en:
| Publicat a: | Curr Pediatr Rep |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4338366/ https://ncbi.nlm.nih.gov/pubmed/25741456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40124-014-0065-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|